| IFN-α Receptor Recognition Peptide 1 (IRRP1) | C35H59N13O12S | 886.00 | 153840-64-3 | H-Cys-Leu-Lys-Asp-Arg-His-Asp-OH |
| IFN-γ Antagonist, (Tyr121,Cys(Acm)122)-IFN-γ Receptor (120-141) (human) | C115H194N34O34S | 2629.08 | 158040-83-6 | H-Ala-Tyr-Cys(Acm)-Arg-Asp-Gly-Lys-Ile-Gly-Pro-Pro-Lys-Leu-Asp-Ile-Arg-Lys-Glu-Glu-Lys-Gln-Ile-OH |
| H-Ala-His-Lys-OH | C15H26N6O4 | 354.41 | 126828-32-8 | H-Ala-His-Lys-OH |
| H-Gly-His-Gly-OH | C10H15N5O4 | 269.26 | 7758-33-0 | H-Gly-His-Gly-OH |
| H-His-Lys-OH | C12H21N5O3 | 283.33 | 151151-29-0 | H-His-Lys-OH |
| GHK, Prezatide, Liver Cell Growth Factor | C14H24N6O4 | 340.38 | 72957-37-0/49557-75-7 | H-Gly-His-Lys-OH |
| SPARC (119-122) (mouse) | C20H36N8O5 | 468.56 | 155149-79-4 | H-Lys-Gly-His-Lys-OH |
| Magainin I | C112H177N29O28S | 2409.88 | 108433-99-4 | H-Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Gly-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Lys-Ser-OH |
| Magainin II | C114H180N30O29S | 2466.93 | 108433-95-0 | H-Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Lys-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Asn-Ser-OH |
| H(-Asn-Pro-Asn-Ala)2-OH | C32H50N12O13 | 810.82 | H-Asn-Pro-Asn-Ala-Asn-Pro-Asn-Ala-OH | |
| H(-Asn-Pro-Asn-Ala)6-OH | C96H146N36O37 | 2396.44 | H-Asn-Pro-Asn-Ala-Asn-Pro-Asn-Ala-Asn-Pro-Asn-Ala-Asn-Pro-Asn-Ala-Asn-Pro-Asn-Ala-Asn-Pro-Asn-Ala-OH | |
| C76H98N16O15S | 1507.78 | 263718-22-5 | DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS Trifluoroacetate salt |
|
| H(-Glu-Glu-Asn-Val)6-OH | C114H176N30O55 | 2846.82 | 138783-15-0 | H-Glu-Glu-Asn-Val-Glu-Glu-Asn-Val-Glu-Glu-Asn-Val-Glu-Glu-Asn-Val-Glu-Glu-Asn-Val-Glu-Glu-Asn-Val-OH |
| GDRADGQPAGDRADGQPA | C68H108N26O29 | 1753.76 | H-Gly-Asp-Arg-Ala-Asp-Gly-Gln-Pro-Ala-Gly-Asp-Arg-Ala-Asp-Gly-Gln-Pro-Ala-OH | |
| LGRSGGDIIKKMQTL | C69H125N21O21S | 1616.95 | H-Leu-Gly-Arg-Ser-Gly-Gly-Asp-Ile-Ile-Lys-Lys-Met-Gln-Thr-Leu-OH | |
| H-Val-Thr-Cys-Gly-OH | C14H26N4O6S | 378.45 | 131204-46-1 | H-Val-Thr-Cys-Gly-OH |
| MART-1 (26-35) (human) Melanoma Antigen Recognized By T-Cells 1 (26-35) (human), Melan-A Protein (26-35) (human), Antigen LB39-AA (26-35) (human), Antigen SK29-AA (26-35) (human) |
C42H74N10O14 | 943.11 | 156251-01-3 | H-Glu-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH Trifluoroacetate salt |
| MART-1 (27-35) (human) Melan A |
C37H67N9O11 | 813.99 | 156251-11-5 | H-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH Acetate salt |
| Mast Cell Degranulating (MCD) Peptide Peptide 401 |
C110H192N40O24S4 | 2587.25 | 32908-73-9 | H-Ile-Lys-Cys-Asn-Cys-Lys-Arg-His-Val-Ile-Lys-Pro-His-Ile-Cys-Arg-Lys-Ile-Cys-Gly-Lys-Asn-NH2 (Disulfide bonds between Cys³ and Cys¹⁵/Cys⁵ and Cys¹⁹) |
| Mast Cell Degranulating (MCD) Peptide HR-1 | C71H133N19O15 | 1492.96 | 80533-94-4 | H-Ile-Asn-Leu-Lys-Ala-Ile-Ala-Ala-Leu-Val-Lys-Lys-Val-Leu-NH2 |
| Mast Cell Degranulating (MCD) Peptide HR-2 | C77H135N17O14 | 1523.03 | 80388-04-1 | H-Phe-Leu-Pro-Leu-Ile-Leu-Gly-Lys-Leu-Val-Lys-Gly-Leu-Leu-NH2 |
| Mastoparan | C70H131N19O15 | 1478.93 | 72093-21-1 | H-Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2 |
| Mastoparan 7 | C67H124N18O15 | 1421.83 | 145854-59-7 | H-Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Ala-Leu-Leu-NH2 |
| Mastoparan 17 | C70H131N19O16 | 1494.93 | 130571-28-7 | H-Ile-Asn-Leu-Lys-Ala-Lys-Ala-Ala-Leu-Ala-Lys-Lys-Leu-Leu-OH |
| Mastoparan X | C73H126N20O15S | 1556.00 | 72093-22-2 | H-Ile-Asn-Trp-Lys-Gly-Ile-Ala-Ala-Met-Ala-Lys-Lys-Leu-Leu-NH2 |
| Polistes Mastoparan | C77H127N21O18 | 1634.99 | 74129-19-4 | H-Val-Asp-Trp-Lys-Lys-Ile-Gly-Gln-His-Ile-Leu-Ser-Val-Leu-NH2 |
| Mating Factor α alpha-Factor, α-Factor, Pheromone α-Factor |
C82H114N20O17S | 1684.01 | 59401-28-4 | H-Trp-His-Trp-Leu-Gln-Leu-Lys-Pro-Gly-Gln-Pro-Met-Tyr-OH |
| Fmoc-Mating Factor α | C97H124N20O19S | 1906.24 | Fmoc-Trp-His-Trp-Leu-Gln-Leu-Lys-Pro-Gly-Gln-Pro-Met-Tyr-OH | |
| Mating Factor α (1-6) | C45H59N11O8 | 882.03 | 65418-88-4 | H-Trp-His-Trp-Leu-Gln-Leu-OH |
| Mating Factor α-SK2 alpha-SK2-Factor, α-SK2-Factor, Pheromone α-SK2-Factor |
C81H106N18O19S | 1667.91 | 89718-47-8 | H-Trp-His-Trp-Leu-Ser-Phe-Ser-Lys-Gly-Glu-Pro-Met-Tyr-OH |
